Synthesis and utility of fluorogenic acetoxymethyl ethers

Chemical Science

Volumn 2, Issue 3, 2011, Pages 521-530

  Lavis, Luke D ^a,b   Chao, Tzu Yuan ^b   Raines, Ronald T ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL SCIENCE; CELLULAR ESTERASE; FLUOROGENICS; IN-VITRO; LOW BACKGROUND; PHENOLIC HYDROXYL GROUP; PHENYL ESTERS; PHENYL ETHERS; RESORUFIN; SMALL MOLECULES;

CHEMICAL STABILITY; ENZYMES; ESTERIFICATION; ESTERS; ETHERS; PHENOLS;

FLUOROPHORES;

EID: 79955010307     PISSN: 20416520     EISSN: 20416539     Source Type: Journal    
DOI: 10.1039/c0sc00466a     Document Type: Article

References (59)

1. L. D. Lavis and R. T. Raines, ACS Chem. Biol., 2008, 3, 142-155.
2. R. P. Haugland, M. T. Z. Spence, I. D. Johnson and A. Basey, The Handbook: A Guide to Fluorescent Probes and Labeling Technologies, 10th edn, Molecular Probes, Eugene, OR, 2005.
3. J.-P. Goddard and J.-L. Reymond, Curr. Opin. Biotechnol., 2004, 15, 314.
4. L. D. Lavis, T.-Y. Chao and R. T. Raines, ACS Chem. Biol., 2006, 1, 252-260.
5. R. Y. Tsien, Nature, 1981, 290, 527-528.
6. J. Kao, A. Harootunian and R. Tsien, J. Biol. Chem., 1989, 264, 8179-8184.
7. B. Rotman and B. W. Papermaster, Proc. Natl. Acad. Sci. U. S. A., 1966, 55, 134-141.
8. B. Testa and J. M. Mayer, Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology, Verlag Helvetica Chimica Acta, Zürich, Switzerland, 2003.
9. L. D. Lavis, ACS Chem. Biol., 2008, 3, 203-206.
10. A. Baeyer, Ber. Dtsch. Chem. Ges., 1871, 4, 555-558.
11. L. D. Lavis, T. J. Rutkoski and R. T. Raines, Anal. Chem., 2007, 79, 6775-6782.
12. W.-C. Sun, K. R. Gee, D. H. Klaubert and R. P. Haugland, J. Org. Chem., 1997, 62, 6469-6475.
13. N. H. Ho, R. Weissleder and C. H. Tung, ChemBioChem, 2007, 8, 560-566.
14. Y. Meyer, J. Richard, M. Massonneau, P. Renard and A. Romieu, Org. Lett., 2008, 10, 1517-1520.
15. J. A. Richard, Y. Meyer, V. Jolivel, M. Massonneau, R. Dumeunier, D. Vaudry, H. Vaudry, P. Y. Renard and A. Romieu, Bioconjugate Chem., 2008, 19, 1707-1718.
16. X. Zhang, M. Waibel and J. Hasserodt, Chem.-Eur. J., 2010, 16, 792-795.
17. R. Sicart, M. P. Collin and J.-L. Reymond, Biotechnol. J., 2007, 2, 221-231.
18. S. S. Chandran, K. A. Dickson and R. T. Raines, J. Am. Chem. Soc., 2005, 127, 1652-1653.
19. L. D. Lavis, T. Y. Chao and R. T. Raines, ChemBioChem, 2006, 7, 1151-1154.
20. M. M. Yatzeck, L. D. Lavis, T. Y. Chao, S. S. Chandran and R. T. Raines, Bioorg. Med. Chem. Lett., 2008, 18, 5864-5866.
21. R. W. Watkins, L. D. Lavis, V. M. Kung, G. V. Los and R. T. Raines, Org. Biomol. Chem., 2009, 7, 3969-3975.
22. P. D. Taylor, Talanta, 1995, 42, 243-248.
23. C. Schultz, M. Vajanaphanich, A. T. Harootunian, P. J. Sammak, K. E. Barrett and R. Y. Tsien, J. Biol. Chem., 1993, 268, 6316-6322.
24. C. Schultz, Bioorg. Med. Chem., 2003, 11, 885-898.
25. N. Bodor, K. B. Sloan, J. J. Kaminski, C. Shih and S. Pogany, J. Org. Chem., 1983, 48, 5280-5284.
26. H. Ouyang, R. T. Borchardt and T. J. Siahaan, Tetrahedron Lett., 2002, 43, 577-579.
27. J. D. Thomas and K. B. Sloan, Tetrahedron Lett., 2007, 48, 109-112.
28. J. Thomas and K. Sloan, Int. J. Pharm., 2008, 346, 80-88.
29. C. Uttamapinant, K. A. White, H. Baruah, S. Thompson, M. Fernández-Suárez, S. Puthenveetil and A. Y. Ting, Proc. Natl. Acad. Sci. U. S. A., 2010, 107, 10914-10919.
30. E. Leroy, N. Bensel and J.-L. Reymond, Bioorg. Med. Chem. Lett., 2003, 13, 2105-2108.
31. N. Bensel, M. T. Reymond and J.-L. Reymond, Chem.-Eur. J., 2001, 7, 4604-4612.
32. Y. Z. Yang, P. Babiak and J.-L. Reymond, Helv. Chim. Acta, 2006, 89, 404-415.
33. Y. Urano, M. Kamiya, K. Kanda, T. Ueno, K. Hirose and T. Nagano, J. Am. Chem. Soc., 2005, 127, 4888-4894.
34. We use the term "apparent" because full fluorescence manifestation requires the removal of two AM ether moieties.
35. B. P. Doctor, T. C. Chapman, C. E. Christner, C. D. Deal, D. M. De La Hoz, M. K. Gentry, R. A. Ogert, R. S. Rush, K. K. Smyth and A. D. Wolfe, FEBS Lett., 1990, 266, 123-127.
36. V. Zanker and W. Peter, Ber. Dtsch. Chem. Ges., 1958, 91, 572-580.
37. I. S. Ioffe and V. F. Otten, Zh. Obshch. Khim., 1965, 1, 343-346.
38. A. G. Miller, Anal. Biochem., 1983, 133, 46-57.
39. B. A. Sparano, S. P. Shahi and K. Koide, Org. Lett., 2004, 6, 1947-1949.
40. L. Mugherli, O. Burchak, F. Chatelain and M. Balakirev, Bioorg. Med. Chem. Lett., 2006, 16, 4488-4491.
41. G. A. Krafft, W. R. Sutton and R. T. Cummings, J. Am. Chem. Soc., 1988, 110, 301-303.
42. T. J. Mitchison, J. Cell Biol., 1989, 109, 637-652.
43. R. P. Haugland, J. J. Naleway and Y.-Z. Zhang, U.S. Patent 5,208,148.
44. K. Kasai, R. Uchida and N. Yamaji, Chem. Pharm. Bull., 1993, 41, 314-318.
45. T. J. Mitchison, K. E. Sawin, J. A. Theriot, K. Gee, A. Mallavarapu and G. Marriott, Methods Enzymol., 1998, 291, 63-78.
46. M. B. Smith and J. March, March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 6th edn, Wiley, Hoboken, New Jersey, 2007.
47. K. B. Sloan and S. A. M. Koch, J. Org. Chem., 1983, 48, 3777-3783.
48. J. Hofmann and M. Sernetz, Anal. Biochem., 1983, 131, 180-186.
49. T. Kobayashi, Y. Urano, M. Kamiya, T. Ueno, H. Kojima and T. Nagano, J. Am. Chem. Soc., 2007, 129, 6696-6697.
50. C. Bueno, M. L. Villegas, S. G. Bertolotti, C. M. Previtali, M. G. Neumann and M. V. Encinas, Photochem. Photobiol., 2002, 76, 385-390.
51. J. Hofmann and M. Sernetz, Anal. Chim. Acta, 1984, 163, 67-72.
52. M. D. Burke, S. Thompson, R. J. Weaver, C. R. Wolf and R. T. Mayer, Biochem. Pharmacol., 1994, 48, 923-936.
53. D. N. Kramer and G. G. Guilbault, Anal. Chem., 1964, 36, 1662-1663.
54. T. M. Kitson, Bioorg. Chem., 1996, 24, 331-339.
55. We note that the values of kcat/KM for the four AM ethers (4a, 4b, 6, and 9) are (106 ± 40)% those of the analogous acetate esters (2a, 2b, 7, and 10, respectively). The insignificant difference between these values is consistent with the breakdown of the hemiacetal formed initially upon AM-ether hydrolysis being rapid (as expected, see: L. H. Funderburk, L. Aldwin and W. P. Jencks, J. Am. Chem. Soc., 1978, 100, 5444-5459) and not limiting the rate of fluorescence generation.
56. C. Klein, H.-G. Batz and R. Herrmann, U.S. Patent 6,800,765.
57. E. Boonacker, J. Stap, A. Koehler and C. J. F. van Noorden, Acta Histochem., 2004, 106, 89-96.
58. J. Golik, H. S. L. Wong, S. H. Chen, T. W. Doyle, J. J. K. Wright, J. Knipe, W. C. Rose, A. M. Casazza and D. M. Vyas, Bioorg. Med. Chem. Lett., 1996, 6, 1837-1842.
59. D. J. Horgan, J. R. Dunstone, J. K. Stoops, E. C. Webb and B. Zerner, Biochemistry, 1969, 8, 2006-2013.